Israel Englander Natera, Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Natera, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,639,254 shares of NTRA stock, worth $281 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,639,254

Previous 1,520,333 73.6%

Holding current value

$281 Million

Previous $95.2 Million 153.47%

% of portfolio

0.11%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$59.21 - $92.9 $66.3 Million - $104 Million	1,118,921 Added 73.6%	2,639,254 $241 Million
Q4 2023 Feb 14, 2024	BUY	$37.55 - $62.64 $30.4 Million - $50.8 Million	810,380 Added 114.15%	1,520,333 $95.2 Million
Q2 2023 Aug 14, 2023	SELL	$47.08 - $55.16 $28.4 Million - $33.3 Million	-603,484 Reduced 45.95%	709,953 $34.5 Million
Q1 2023 May 15, 2023	BUY	$36.57 - $58.29 $11.4 Million - $18.2 Million	311,676 Added 31.11%	1,313,437 $72.9 Million
Q4 2022 Feb 14, 2023	SELL	$34.17 - $47.91 $36.4 Million - $51 Million	-1,064,024 Reduced 51.51%	1,001,761 $40.2 Million

Q3 2022 Nov 14, 2022	SELL	$36.93 - $56.68 $25.6 Million - $39.2 Million	-692,096 Reduced 25.1%	2,065,785 $90.5 Million
Q2 2022 Aug 15, 2022	BUY	$28.13 - $44.54 $10.4 Million - $16.5 Million	371,336 Added 15.56%	2,757,881 $97.7 Million
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $32.1 Million - $96.7 Million	1,058,820 Added 79.75%	2,386,545 $97.1 Million
Q4 2021 Feb 14, 2022	BUY	$86.26 - $119.0 $11.5 Million - $15.8 Million	132,840 Added 11.12%	1,327,725 $124 Million
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $71.9 Million - $90.7 Million	-717,586 Reduced 37.52%	1,194,885 $133 Million
Q2 2021 Aug 16, 2021	BUY	$86.05 - $119.72 $24.3 Million - $33.9 Million	282,769 Added 17.35%	1,912,471 $217 Million
Q1 2021 May 17, 2021	BUY	$91.47 - $124.36 $16.8 Million - $22.9 Million	184,159 Added 12.74%	1,629,702 $165 Million
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $6.57 Million - $11 Million	98,577 Added 7.32%	1,445,543 $144 Million
Q3 2020 Nov 16, 2020	BUY	$45.89 - $72.67 $20.2 Million - $32 Million	439,717 Added 48.47%	1,346,966 $97.3 Million
Q2 2020 Aug 14, 2020	SELL	$26.36 - $49.86 $23.3 Million - $44.1 Million	-885,167 Reduced 49.38%	907,249 $45.2 Million
Q1 2020 May 14, 2020	BUY	$17.27 - $40.17 $1.3 Million - $3.03 Million	75,359 Added 4.39%	1,792,416 $53.5 Million
Q4 2019 Feb 14, 2020	SELL	$32.1 - $40.4 $15.2 Million - $19.2 Million	-474,676 Reduced 21.66%	1,717,057 $57.8 Million
Q3 2019 Nov 14, 2019	BUY	$25.38 - $34.89 $2.22 Million - $3.06 Million	87,563 Added 4.16%	2,191,733 $71.9 Million
Q2 2019 Aug 15, 2019	BUY	$17.75 - $27.58 $35 Million - $54.4 Million	1,972,357 Added 1496.33%	2,104,170 $58 Million
Q2 2019 Aug 14, 2019	SELL	$17.75 - $27.58 $51.2 Million - $79.6 Million	-2,886,308 Reduced 95.63%	131,813 $113,000
Q1 2019 May 14, 2019	BUY	$11.34 - $20.62 $15 Million - $27.3 Million	1,322,904 Added 78.04%	3,018,121 $62.2 Million
Q4 2018 Feb 14, 2019	SELL	$12.32 - $24.38 $3.58 Million - $7.09 Million	-290,739 Reduced 14.64%	1,695,217 $23.7 Million
Q3 2018 Nov 14, 2018	BUY	$18.82 - $28.96 $23.4 Million - $35.9 Million	1,241,358 Added 166.72%	1,985,956 $47.5 Million
Q2 2018 Aug 14, 2018	BUY	$8.79 - $19.98 $3.77 Million - $8.56 Million	428,376 Added 135.47%	744,598 $14 Million
Q1 2018 May 15, 2018	BUY	$9.0 - $11.95 $1.95 Million - $2.59 Million	216,987 Added 218.66%	316,222 $2.93 Million
Q4 2017 Feb 14, 2018	SELL	$8.99 - $14.31 $314,632 - $500,821	-34,998 Reduced 26.07%	99,235 $892,000
Q3 2017 Nov 14, 2017	BUY	$8.02 - $13.33 $1.08 Million - $1.79 Million	134,233	134,233 $1.73 Million

Others Institutions Holding NTRA

# of Institutions

439

Shares Held

117M

Call Options Held

254K

Put Options Held

263K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $10.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account